切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2017, Vol. 11 ›› Issue (01) : 58 -61. doi: 10.3877/cma.j.issn.1674-3253.2017.01.014

所属专题: 文献

临床研究

前列腺体积对经尿道前列腺电切术治疗效果的影响
刘和谦1, 陈弋生1,(), 邹滨1, 孔艰1, 陶凌松1, 朱光标1, 陶良俊1   
  1. 1. 241000 芜湖市第二人民医院泌尿外科,安徽省芜湖市前列腺疾病研究所
  • 收稿日期:2015-05-30 出版日期:2017-02-01
  • 通信作者: 陈弋生
  • 基金资助:
    安徽省省卫生厅资助课题(09A070)

The impact of prostate volume on the outcomes of transurethral resection of the prostate

Heqian Liu1, Yisheng Chen1,(), Bin Zou1, Jian Kong1, Lingsong Tao1, Guangbiao Zhu1, Liangjun Tao1   

  1. 1. Department of Urology & Institute of Prostatic Diseases, the Second People's Hospital of Wuhu, Anhui 241000, China
  • Received:2015-05-30 Published:2017-02-01
  • Corresponding author: Yisheng Chen
  • About author:
    Corresponding author: Chen Yisheng, Email:
引用本文:

刘和谦, 陈弋生, 邹滨, 孔艰, 陶凌松, 朱光标, 陶良俊. 前列腺体积对经尿道前列腺电切术治疗效果的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2017, 11(01): 58-61.

Heqian Liu, Yisheng Chen, Bin Zou, Jian Kong, Lingsong Tao, Guangbiao Zhu, Liangjun Tao. The impact of prostate volume on the outcomes of transurethral resection of the prostate[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2017, 11(01): 58-61.

目的

评估前列腺体积对经尿道前列腺电切术治疗效果的影响。

方法

回顾性分析我院2012年1月至2014年7月收治的220例行经尿道前列腺电切术患者资料,所有患者术后病理均为良性前列腺增生。根据前列腺体积将患者分为三组:A组前列腺体积(PV)<40 ml,B组PV 40~80 ml,C组PV>80 ml。统计所有患者术前及术后1个月国际前列腺症状评分(IPSS),生活质量评分(QOL)、最大尿流率(Qmax)、平均尿流率(Qave)、残余尿量(RUV)、前列腺特异抗原(PSA)及术后并发症等数据资料。

结果

A组51例,年龄(71±10)岁;B组107例,年龄(71±9)岁;C组62例,年龄(72±7)岁。三组患者除前列腺体积外其他术前基础指标差异无统计学意义(P>0.05),术中及术后并发症发生情况差异无统计学意义(P>0.05),术后排尿情况较术前明显改善,但三组间比较,仅Q-max和Q-ave手术前后变化值差异有统计学意义(P<0.05),IPSS、QOL及RUV组间比较差异无统计学意义(P>0.05)。

结论

前列腺体积大小不是经尿道前列腺电切术并发症发生决定因素,不限制前列腺电切术适应范围,不影响主观排尿困难症状和生活质量评分,但中度前列腺增生者(PV= 40~80 ml)电切术后尿流率改善更明显。

Objective

To investigate the effect of prostate volume on the outcomes of transurethral resection of the prostate (TURP).

Methods

A retrospective study was conducted to summarize the cases who received TURP for BPH from January 2012 to July 2014. These patients were divided into three groups according to different prostate volume (PV) (Group A: PV<40 ml; Group B: PV=40~80 ml; Group C: PV>80 ml). The international prostate symptom score (IPSS), qulity of life score(QOL), maximum urine flow(Qmax), average flow rate (Qave), residual urine volume (RUV), prostate-specific antigen (PSA) and the postoperative complications in all patients were compared between pre- and post-surgery.

Results

Group A: 51 patients, (71±10) years old, Group B: 107 patients, (71±9) years old, Group C: 62 patients, (72±7) years old. No statistically significant differences were observed on all indicators of preoperative and complications after TURP(P>0.05). All patients urination improved after surgery, but among the three groups, only the Qmax and Qave changes were statistically significant (P<0.05), no significant difference between the IPSS, QOL and RUV changes (P>0.05).

Conclusions

Prostate volume does not affect the choice of TURP, also does not affect the improvement of dysuria symptoms and quality of life, but urinary flow rate improvement was significant for moderate benign prostatic hyperplasia (PV=40~80 ml).

表1 术前三组患者基础特征的比较(±s
表2 三组患者手术时间及术后并发症的情况比较
表3 三组患者手术前后相关指标的变化情况
[1]
Thomas AW, Abrams P. Lower urinary tract symptoms, benign prostatic obstruction and the overactive bladder[J]. BJU Int, 2000, 85 Suppl, 3: 57-68.
[2]
Oelke M, Bachmann A, Descazeaud AA, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction[J]. Eur Urol, 2013, 64(1): 118-140.
[3]
陈弋生,邹滨,孔艰,等.三种经尿道术式治疗良性前列腺增生的疗效比较[J/CD].中华腔镜泌尿外科杂志:电子版, 2011, 5(6): 489-492.
[4]
Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia[J].J Clin Endocfinol Metab, 2006, 91(7): 2562-2568.
[5]
Chen IH, Tsai YS, Tong YC. Correlations among cardiovascular risk factors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia[J]. Urology, 2012, 79(2): 409-414.
[6]
Udeh EI, Ozoemena OF, Ogwuche E. The relationship between prostate volume and international prostate symptom score in Africans with benign prostatic hyperplasia[J]. Niger J Med, 2013, 21(3): 290-295.
[7]
张争,张祥华,李昕,等.中老年男性前列腺体积和最大尿流率的相关性分析[J].中华临床医师杂志:电子版, 2009, 3(9): 1491-1495.
[8]
Vesely S, Knutson T, Damber JE, et al. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms[J]. Scand J Urol Nephrol, 2003, 37(4): 322-328.
[9]
Bosch JL, Hop WC, Kirkels WJ, et al. The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume[J]. Br J Urol, 1995, 75(5): 622-630.
[10]
Joshi HN, De Jong IJ, Karmacharya RM, et al. Outcomes of transurethral resection of the prostate in benign prostatic hyperplasia comparing prostate size of more than 80 grams to prostate size less than 80 grams[J]. Kathmandu Univ Med J (KUMJ), 2015, 12(47): 163-167.
[11]
Yucel M, Aras B, Yalcinkaya S, et al. Conventional monopolar transurethral resection of prostate in patients with large prostate (≥80 grams)[J]. Cent European J Urol, 2013, 66(3): 303-308.
[12]
Muzzonigro G, Milanese G, Minardi D, et al. Safety and efficacy of transurethral resection of prostate glands up to 150 ml: a prospective comparative study with 1 year of followup[J]. J Urol, 2004, 172(2): 611-615.
[13]
Al-Hammouri F, Abu-Qamar A. Monopolar transurethral resection of the big prostate, experience at Prince Hussein Bin Abdullah Urology Center[J]. J Pak Med Assoc, 2011, 61(7): 628-631.
[14]
Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement[J]. Eur Urol, 2010, 58(3): 384-397.
[15]
赵虎,吴斌,袁军,等.前列腺突入膀胱程度对前列腺电切术后效果评估的价值[J/CD].中华腔镜泌尿外科杂志:电子版, 2014, 8(4): 6-9.
[16]
张浩,司徒杰,张炎,等.膀胱内前列腺突出程度可作为良性前列腺增生临床进展的高危因素[J/CD].中华腔镜泌尿外科杂志:电子版, 2012, 6(4): 292-295.
[1] 李辉, 尉维录, 吴茂林. 经直肠剪切波弹性成像对存在下尿路症状的前列腺病变良恶性的鉴别诊断价值及其影响因素分析[J/OL]. 中华医学超声杂志(电子版), 2023, 20(11): 1193-1198.
[2] 程志刚, 魏辉, 李一波, 韩健, 钟永豪, 王铭, 张文辉, 周传东. 经尿道前列腺剜除术中保留前列腺分叶沟间组织对术后顺行射精功能的保护[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 453-458.
[3] 李想, 郭征, 田洪哲, 李杜, 熊梦瑶, 潘铁军. 1 470 nm半导体激光减容性切除治疗高危前列腺增生的临床研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 448-452.
[4] 杨登科, 蔡明志, 张星星, 胡青, 郭大勇, 高喆, 毕永启, 胡伟. 腹腔镜膀胱颈Y-V成形术与经尿道膀胱颈电切治疗膀胱颈挛缩的比较[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 392-396.
[5] 莫林键, 杨舒博, 农卫赟, 程继文. 人工智能虚拟数字医师在钬激光前列腺剜除日间手术患教管理中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 318-322.
[6] 潘兴赫, 董翔, 杨海洋, 张雪斌, 甘卫东. 超选择性前列腺动脉栓塞治疗伴急性尿潴留的高危高龄前列腺增生[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 237-242.
[7] 曾明辉, 蒋东方, 秦锁炳. 钬激光前列腺剜除术治疗前列腺增生疗效的影响因素[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 157-161.
[8] 汪洋, 李志鹏, 张楠, 何海填, 杨伟锋, 张焕灵, 王可兵. 保护射精技术在前列腺等离子剜除术中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 152-156.
[9] 张铭星, 刘文倩, 王以然, 赵泽恬, 袁欣怡, 丁留成. 江苏地区腹腔镜下前列腺癌根治术后一年夜尿症发生率及相关危险因素多中心回顾性研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 141-145.
[10] 李俊涛, 张天佑, 叶雷, 郭强, 吴坚坚, 尧冰, 王德娟, 邱剑光. 保留"尿道系膜"的腹腔镜下前列腺根治性切除术后尿控情况的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 19-24.
[11] 李俊涛, 张天佑, 叶雷, 郭强, 吴坚坚, 尧冰, 王德娟, 邱剑光. 保留"尿道系膜"的腹腔镜下前列腺根治性切除术后尿控情况的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 19-24.
[12] 李腾成, 黄群雄, 胡成, 肖恒军, 徐锦斌, 高舜天, 黄展森, 高新, 狄金明. 机器人腹腔镜后入路筋膜内和筋膜外根治性前列腺切除术技术分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 12-18.
[13] 梅鑫, 张世科, 张巧珍, 吴文起. 前列腺增生导致下尿路症状手术时机的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 96-99.
[14] 熊风, 林辉煌, 陈晓波. 铥激光在泌尿外科中的临床应用及研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 533-536.
[15] 韩广玮, 申雪晴, 吴涵潇, 曹炎武, 唐黎明. 前列腺增生并轻度尿道狭窄行去外鞘半导体激光汽化剜除与等离子电切的比较[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 490-494.
阅读次数
全文


摘要